ASP Isotopes Inc. has announced that effective October 1, 2025, Paul Mann, the company's founder, Chairman, and CEO, will become Executive Chairman and take a temporary leave of absence from his CEO duties for health reasons. Chief Operating Officer Robert Ainscow has been appointed Interim Chief Executive Officer, assuming responsibility for managing the company's operations and key stakeholder communications. Mann will continue to oversee the company's strategic direction and work with the board and senior management.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ASP Isotopes Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-25-007343), on October 03, 2025, and is solely responsible for the information contained therein.